Conditioning Regimen Containing Melphalan and Cladribine for Refractory / Relapsed AML
Clinical trial NCT06133556 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06133556
- Sponsor
- Institute of Hematology & Blood Diseases Hospital, China
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-24
- Primary completion
- 2028-10-20
- Enrollment
- 237
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.